Rockwell Medical Technologies (RMTI) Says it Filed Calcitriol Post-Approval Manufacturing Submission with FDA
Tweet Send to a Friend
Rockwell Medical, Inc. (NASDAQ: RMTI), today provided an update on the commercial launch of Calcitriol, stating that it has submitted ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
